Antiplatelet Therapy

Page 1 <img data-url='document/antiplatelet-therapy.html?page=1' data-page='1' class='cut-thumb lazyload' alt='Page 1: Antiplatelet Therapy' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader040.cupdf.com/reader040/viewer/2022031706/56812c93550346895d91401c/html5/thumbnails/1.jpg' width='140' height='200' /> Page 2 <img data-url='document/antiplatelet-therapy.html?page=2' data-page='2' class='cut-thumb lazyload' alt='Page 2: Antiplatelet Therapy' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader040.cupdf.com/reader040/viewer/2022031706/56812c93550346895d91401c/html5/thumbnails/2.jpg' width='140' height='200' /> Antiplatelet Therapy

Page 3 <img data-url='document/antiplatelet-therapy.html?page=3' data-page='3' class='cut-thumb lazyload' alt='Page 3: Antiplatelet Therapy' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader040.cupdf.com/reader040/viewer/2022031706/56812c93550346895d91401c/html5/thumbnails/3.jpg' width='140' height='200' /> Page 4 <img data-url='document/antiplatelet-therapy.html?page=4' data-page='4' class='cut-thumb lazyload' alt='Page 4: Antiplatelet Therapy' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader040.cupdf.com/reader040/viewer/2022031706/56812c93550346895d91401c/html5/thumbnails/4.jpg' width='140' height='200' /> CHAMPION PHOENIX: Primary Efficacy Outcomes at 48

Hours, MITT

Page 5 <img data-url='document/antiplatelet-therapy.html?page=5' data-page='5' class='cut-thumb lazyload' alt='Page 5: Antiplatelet Therapy' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader040.cupdf.com/reader040/viewer/2022031706/56812c93550346895d91401c/html5/thumbnails/5.jpg' width='140' height='200' /> TRITON-TIMI 3813,608 Patients With ACS and Planned PCI Randomized to Prasugrel (60/10) vs

Clopidogrel (300/75)

Page 6 <img data-url='document/antiplatelet-therapy.html?page=6' data-page='6' class='cut-thumb lazyload' alt='Page 6: Antiplatelet Therapy' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader040.cupdf.com/reader040/viewer/2022031706/56812c93550346895d91401c/html5/thumbnails/6.jpg' width='140' height='200' /> TRITON-TIMI 38 Bleeding Events: Safety Cohort (N = 13,457)

Page 7 <img data-url='document/antiplatelet-therapy.html?page=7' data-page='7' class='cut-thumb lazyload' alt='Page 7: Antiplatelet Therapy' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader040.cupdf.com/reader040/viewer/2022031706/56812c93550346895d91401c/html5/thumbnails/7.jpg' width='140' height='200' /> Page 8 <img data-url='document/antiplatelet-therapy.html?page=8' data-page='8' class='cut-thumb lazyload' alt='Page 8: Antiplatelet Therapy' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader040.cupdf.com/reader040/viewer/2022031706/56812c93550346895d91401c/html5/thumbnails/8.jpg' width='140' height='200' /> Page 9 <img data-url='document/antiplatelet-therapy.html?page=9' data-page='9' class='cut-thumb lazyload' alt='Page 9: Antiplatelet Therapy' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader040.cupdf.com/reader040/viewer/2022031706/56812c93550346895d91401c/html5/thumbnails/9.jpg' width='140' height='200' /> PLATO: Overall Mortality and CABG-Related Bleeding Rates

Page 10 <img data-url='document/antiplatelet-therapy.html?page=10' data-page='10' class='cut-thumb lazyload' alt='Page 10: Antiplatelet Therapy' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader040.cupdf.com/reader040/viewer/2022031706/56812c93550346895d91401c/html5/thumbnails/10.jpg' width='140' height='200' /> Page 11 <img data-url='document/antiplatelet-therapy.html?page=11' data-page='11' class='cut-thumb lazyload' alt='Page 11: Antiplatelet Therapy' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader040.cupdf.com/reader040/viewer/2022031706/56812c93550346895d91401c/html5/thumbnails/11.jpg' width='140' height='200' /> TiCAB Study Design

Page 12 <img data-url='document/antiplatelet-therapy.html?page=12' data-page='12' class='cut-thumb lazyload' alt='Page 12: Antiplatelet Therapy' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader040.cupdf.com/reader040/viewer/2022031706/56812c93550346895d91401c/html5/thumbnails/12.jpg' width='140' height='200' /> Postoperative Management

Page 13 <img data-url='document/antiplatelet-therapy.html?page=13' data-page='13' class='cut-thumb lazyload' alt='Page 13: Antiplatelet Therapy' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader040.cupdf.com/reader040/viewer/2022031706/56812c93550346895d91401c/html5/thumbnails/13.jpg' width='140' height='200' /> Abbreviations

Page 14 <img data-url='document/antiplatelet-therapy.html?page=14' data-page='14' class='cut-thumb lazyload' alt='Page 14: Antiplatelet Therapy' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader040.cupdf.com/reader040/viewer/2022031706/56812c93550346895d91401c/html5/thumbnails/14.jpg' width='140' height='200' /> Abbreviations (cont)

Page 15 <img data-url='document/antiplatelet-therapy.html?page=15' data-page='15' class='cut-thumb lazyload' alt='Page 15: Antiplatelet Therapy' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader040.cupdf.com/reader040/viewer/2022031706/56812c93550346895d91401c/html5/thumbnails/15.jpg' width='140' height='200' /> References

Page 16 <img data-url='document/antiplatelet-therapy.html?page=16' data-page='16' class='cut-thumb lazyload' alt='Page 16: Antiplatelet Therapy' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader040.cupdf.com/reader040/viewer/2022031706/56812c93550346895d91401c/html5/thumbnails/16.jpg' width='140' height='200' /> References (cont)

Antiplatelet Therapy

Documents

mitt tritontimi

bleeding events

primary efficacy outcomes

overall mortality

safety cohort n

planned pci